John Nelson Email & Phone Number

San Rafael, Ca, Us

Responsible for US pricing across full portfolio of products, launch pricing, pipeline/LCM pricing insights and strategy, gross-to-net forecasting, contracting strategy and execution, payer market research, and payer advisory boards. Oversees government price reporting, pricing governance, and channel/payer contracting operations and analytics. Experienced in gene therapy pricing and contracting and generic/LOE contracting strategies.

San Rafael, Ca, Us

Thousand Oaks, Ca, Us

Global Access Strategy Lead for early hematology oncology pipeline covering 10+ assets including small molecules (oral and IV), bi-specifics, antibody-drug conjugates (ADCs), and CAR T-cell therapies being explored primarily in Acute Myeloid Leukemia and Multiple Myeloma. Primary responsibilities were to drive product strategy, generate market insights, influence development, and develop pricing and market access strategies and forecast assumptions to prepare for successful launch.

South San Francisco, Ca, Us

Supported the global phase 3 "ASPIRE/KRd" launch of KYPROLIS in Multiple Myeloma. Key accomplishments include the development and execution of the KYPROLIS global launch pricing and market access strategy; the creation of the KYPROLIS “Global Value Dossier,” which served the basis for world-wide payer submissions, value communications, and price/contract negotiations; and the training of regional and local affiliates on pricing strategy, value story, payer negotiation, and contracting strategies.Beyond the initial global "ASPIRE/KRd" launch, performed all necessary strategy and value story updates/training to support the launch of 2 additional phase 3 studies (“ENDEAVOR/Kd” and “CLARION/KMP” studies). Also provided significant strategic input to the KYPROLIS lifecycle management strategy including the design of the phase 3 “CANDOR/KDd” and "ARROW/Kd QW" studies.Transitioned to Amgen in 2015 as part of Onyx integration. Became Global Payer Lead for two early oncology programs in 2017.

Durham, North Carolina, Us

Project Manager and consultant for over 30 management consulting projects focused on asset pricing, market access, value messaging, forecasting, segmentation, reimbursement, and contracting. Therapeutic areas covered include oncology (solid tumor and hematological), cardiology, diabetes, schizophrenia, depression, osteoarthritis, uveitis, and acne. While at IQVIA, developed expertise with primary research methodologies such as choice/allocation/adaptive conjoint design, quantitative survey development, in-depth interviews, focus groups, advisory boards, and dyads. Also gained deep understanding of global pricing and reimbursement systems in United States, Europe, Canada, Japan, and multiple emerging markets including Brazil, Russia, Turkey, China, and Mexico. Also contributed to IQVIA Thought Leadership with topics including US Healthcare Reform, US Payment Reform, primary research methodologies, and knowledge management. Was promoted from Consultant to Senior Consultant in 2013.

New York, Ny, Us

Responsible for analytics, valuations, and primary research (payers, physicians, nurses) for 2 projects focusing on 1) growth hormone market growth opportunities and 2) lifecycle management for novel anti-thrombotic therapy. Identified additional revenue opportunities (~$55M) by developing scenario models of patient compliance, price, volume, diagnosis rate, payer behavior, and technology improvement.

Abbott Park, Illinois, Us

Engineering Project Team Leader and design engineer for multiple new coronary guidewire development programs. Supported marketing and sales force interactions with interventional cardiologists by providing training on the technology and answering technical questions about the development and construction of the products.

Thousand Oaks, Ca, Us

New Brunswick, Nj, Us

Mba, Business Strategy, Marketing, Life Sciences

B.S., Materials Engineering

M.S., Biomedical Engineering